Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024
Gritstone bio, Inc. (GRTS)
Last gritstone bio, inc. earnings: 11/12 09:01 am
Check Earnings Report
Company Research
Source: GlobeNewswire
-- IgG levels and neutralizing antibodies against variants of concern persisted for at least 12 months, consistent with previous findings -- -- Antigen-specific T cell responses increased in the majority of participants studied, including those living with HIV, after administration of any of the samRNA constructs -- -- Comprehensive data set demonstrates a consistent and strong immunogenicity profile across multiple patient populations in South Africa, including people living with HIV -- EMERYVILLE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today presented updated Phase 1 data from its CORAL-CEPI study, a Coalition for Epidemic Preparedness Innovations (CEPI)-funded study that is evaluating Gritstone’s self-amplifying mRNA (samRNA) vaccine against COVID-19 in HIV-negative and people living with HIV (PLWH) participants. The presentation, at ESCMID Global
Show less
Read more
Impact Snapshot
Event Time:
GRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRTS alerts
High impacting Gritstone bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRTS
News
- Gritstone bio, Inc. (NASDAQ: GRTS) had its price target lowered by analysts at HC Wainwright from $7.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings [Yahoo! Finance]Yahoo! Finance
GRTS
Earnings
- 5/9/24 - Miss
GRTS
Sec Filings
- 5/10/24 - Form DEFA14A
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- GRTS's page on the SEC website